Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia

Domenico Frezza, V. Giambra, C. Mattioli, K. Piccoli, R. Massoud, A. Siracusano, M. Di Giannantonio, B. K. Birshtein, I. A. Rubino

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Infectious and autoimmune pathogenic hypotheses of schizophrenia have been proposed, prompting searches for antibodies against viruses or brain structures, and for altered levels of immunoglobulins. Previous experiments have shown that allele frequencies of the Ig heavy chain 3′ enhancer HS1,2*A are associated with several autoimmune diseases, suggesting a possible correlation between HS1,2 alleles and Ig production. To test this, we analyzed levels of serum Igs and HS1,2*A genotypes in two independent cohorts, one of 88 schizophrenic inpatients (24 women) and a second of 133 healthy subjects (59 women). Both groups were similar in the frequency of individuals with altered serum concentration of Ig classes and IgG subclasses (schizophrenia panel-80%; controls-68%). With the possible exception of a stabilizing effect of olanzapine, no psychopharmacological drug consumed during the month prior to serum sampling in the schizophrenia group significantly affected Ig levels. In both patient and control cohorts, an increased frequency of the HS1,2*2A allele corresponded to increased Ig plasma levels, while an increased frequency of the HS1,2*1A affele corresponded to decreased Ig plasma levels. EMSA analysis with nuclear extracts from human B cells showed that the transcription factor SP1 bound to the polymorphic region of both HS1,2*1A and HS1,2*2A while NF-κB bound only to the HS1,2*2A. We predict that differences in transcription factor binding sites in the two allelic variants of the 3′ IgH enhancer HS1,2 may provide a mechanism by which differences in Ig expression are affected.

Original languageEnglish (US)
Pages (from-to)115-123
Number of pages9
JournalInternational Journal of Immunopathology and Pharmacology
Volume22
Issue number1
StatePublished - Jan 2009

Fingerprint

Immunoglobulin Heavy Chains
Schizophrenia
olanzapine
Transcription Factors
Serum
Alleles
Gene Frequency
Autoimmune Diseases
Immunoglobulins
Inpatients
Healthy Volunteers
B-Lymphocytes
Immunoglobulin G
Binding Sites
Genotype
Viruses
Antibodies
Brain
Pharmaceutical Preparations

Keywords

  • 2 alleles
  • EMSA
  • HSI
  • Ig3' regulatory region
  • NF-κB
  • Pharmacologic antipsychotic treatment
  • Plasma Ig levels

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Frezza, D., Giambra, V., Mattioli, C., Piccoli, K., Massoud, R., Siracusano, A., ... Rubino, I. A. (2009). Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia. International Journal of Immunopathology and Pharmacology, 22(1), 115-123.

Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia. / Frezza, Domenico; Giambra, V.; Mattioli, C.; Piccoli, K.; Massoud, R.; Siracusano, A.; Di Giannantonio, M.; Birshtein, B. K.; Rubino, I. A.

In: International Journal of Immunopathology and Pharmacology, Vol. 22, No. 1, 01.2009, p. 115-123.

Research output: Contribution to journalArticle

Frezza, D, Giambra, V, Mattioli, C, Piccoli, K, Massoud, R, Siracusano, A, Di Giannantonio, M, Birshtein, BK & Rubino, IA 2009, 'Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia', International Journal of Immunopathology and Pharmacology, vol. 22, no. 1, pp. 115-123.
Frezza, Domenico ; Giambra, V. ; Mattioli, C. ; Piccoli, K. ; Massoud, R. ; Siracusano, A. ; Di Giannantonio, M. ; Birshtein, B. K. ; Rubino, I. A. / Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia. In: International Journal of Immunopathology and Pharmacology. 2009 ; Vol. 22, No. 1. pp. 115-123.
@article{2181ac73598b47858ed62e4b61bc4602,
title = "Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia",
abstract = "Infectious and autoimmune pathogenic hypotheses of schizophrenia have been proposed, prompting searches for antibodies against viruses or brain structures, and for altered levels of immunoglobulins. Previous experiments have shown that allele frequencies of the Ig heavy chain 3′ enhancer HS1,2*A are associated with several autoimmune diseases, suggesting a possible correlation between HS1,2 alleles and Ig production. To test this, we analyzed levels of serum Igs and HS1,2*A genotypes in two independent cohorts, one of 88 schizophrenic inpatients (24 women) and a second of 133 healthy subjects (59 women). Both groups were similar in the frequency of individuals with altered serum concentration of Ig classes and IgG subclasses (schizophrenia panel-80{\%}; controls-68{\%}). With the possible exception of a stabilizing effect of olanzapine, no psychopharmacological drug consumed during the month prior to serum sampling in the schizophrenia group significantly affected Ig levels. In both patient and control cohorts, an increased frequency of the HS1,2*2A allele corresponded to increased Ig plasma levels, while an increased frequency of the HS1,2*1A affele corresponded to decreased Ig plasma levels. EMSA analysis with nuclear extracts from human B cells showed that the transcription factor SP1 bound to the polymorphic region of both HS1,2*1A and HS1,2*2A while NF-κB bound only to the HS1,2*2A. We predict that differences in transcription factor binding sites in the two allelic variants of the 3′ IgH enhancer HS1,2 may provide a mechanism by which differences in Ig expression are affected.",
keywords = "2 alleles, EMSA, HSI, Ig3' regulatory region, NF-κB, Pharmacologic antipsychotic treatment, Plasma Ig levels",
author = "Domenico Frezza and V. Giambra and C. Mattioli and K. Piccoli and R. Massoud and A. Siracusano and {Di Giannantonio}, M. and Birshtein, {B. K.} and Rubino, {I. A.}",
year = "2009",
month = "1",
language = "English (US)",
volume = "22",
pages = "115--123",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "1",

}

TY - JOUR

T1 - Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia

AU - Frezza, Domenico

AU - Giambra, V.

AU - Mattioli, C.

AU - Piccoli, K.

AU - Massoud, R.

AU - Siracusano, A.

AU - Di Giannantonio, M.

AU - Birshtein, B. K.

AU - Rubino, I. A.

PY - 2009/1

Y1 - 2009/1

N2 - Infectious and autoimmune pathogenic hypotheses of schizophrenia have been proposed, prompting searches for antibodies against viruses or brain structures, and for altered levels of immunoglobulins. Previous experiments have shown that allele frequencies of the Ig heavy chain 3′ enhancer HS1,2*A are associated with several autoimmune diseases, suggesting a possible correlation between HS1,2 alleles and Ig production. To test this, we analyzed levels of serum Igs and HS1,2*A genotypes in two independent cohorts, one of 88 schizophrenic inpatients (24 women) and a second of 133 healthy subjects (59 women). Both groups were similar in the frequency of individuals with altered serum concentration of Ig classes and IgG subclasses (schizophrenia panel-80%; controls-68%). With the possible exception of a stabilizing effect of olanzapine, no psychopharmacological drug consumed during the month prior to serum sampling in the schizophrenia group significantly affected Ig levels. In both patient and control cohorts, an increased frequency of the HS1,2*2A allele corresponded to increased Ig plasma levels, while an increased frequency of the HS1,2*1A affele corresponded to decreased Ig plasma levels. EMSA analysis with nuclear extracts from human B cells showed that the transcription factor SP1 bound to the polymorphic region of both HS1,2*1A and HS1,2*2A while NF-κB bound only to the HS1,2*2A. We predict that differences in transcription factor binding sites in the two allelic variants of the 3′ IgH enhancer HS1,2 may provide a mechanism by which differences in Ig expression are affected.

AB - Infectious and autoimmune pathogenic hypotheses of schizophrenia have been proposed, prompting searches for antibodies against viruses or brain structures, and for altered levels of immunoglobulins. Previous experiments have shown that allele frequencies of the Ig heavy chain 3′ enhancer HS1,2*A are associated with several autoimmune diseases, suggesting a possible correlation between HS1,2 alleles and Ig production. To test this, we analyzed levels of serum Igs and HS1,2*A genotypes in two independent cohorts, one of 88 schizophrenic inpatients (24 women) and a second of 133 healthy subjects (59 women). Both groups were similar in the frequency of individuals with altered serum concentration of Ig classes and IgG subclasses (schizophrenia panel-80%; controls-68%). With the possible exception of a stabilizing effect of olanzapine, no psychopharmacological drug consumed during the month prior to serum sampling in the schizophrenia group significantly affected Ig levels. In both patient and control cohorts, an increased frequency of the HS1,2*2A allele corresponded to increased Ig plasma levels, while an increased frequency of the HS1,2*1A affele corresponded to decreased Ig plasma levels. EMSA analysis with nuclear extracts from human B cells showed that the transcription factor SP1 bound to the polymorphic region of both HS1,2*1A and HS1,2*2A while NF-κB bound only to the HS1,2*2A. We predict that differences in transcription factor binding sites in the two allelic variants of the 3′ IgH enhancer HS1,2 may provide a mechanism by which differences in Ig expression are affected.

KW - 2 alleles

KW - EMSA

KW - HSI

KW - Ig3' regulatory region

KW - NF-κB

KW - Pharmacologic antipsychotic treatment

KW - Plasma Ig levels

UR - http://www.scopus.com/inward/record.url?scp=62649145611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62649145611&partnerID=8YFLogxK

M3 - Article

C2 - 19309558

AN - SCOPUS:62649145611

VL - 22

SP - 115

EP - 123

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 1

ER -